Company Data

Rallybio Corporation

Ticker
RLYB
Current Price
$0.754 -2.09%
Market Cap
$31.3M
Price Target
Refer to Report
Volume
49.5K
52wk Range
$0.725 - $3.46
Advanced Market Data

Overview

Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy